Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Patient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014.

Mishra SI, Sussman AL, Murrietta AM, Getrich CM, Rhyne R, Crowell RE, Taylor KL, Reifler EJ, Wescott PH, Saeed AI, Hoffman RM.

Prev Chronic Dis. 2016 Aug 18;13:E108. doi: 10.5888/pcd13.160093.

2.

Smoking cessation and lung cancer screening.

Pedersen JH, Tønnesen P, Ashraf H.

Ann Transl Med. 2016 Apr;4(8):157. doi: 10.21037/atm.2016.03.54. Review.

3.

Effectiveness of advice from physician and nurse on smoking cessation stage in Taiwanese male smokers attending a community-based integrated screening program.

Luh DL, Chen SL, Yen AM, Chiu SY, Fann CY, Chen HH.

Tob Induc Dis. 2016 Apr 23;14:15. doi: 10.1186/s12971-016-0080-0. eCollection 2016.

4.

Pulmonary nodules and CT screening: the past, present and future.

Ruparel M, Quaife SL, Navani N, Wardle J, Janes SM, Baldwin DR.

Thorax. 2016 Apr;71(4):367-75. doi: 10.1136/thoraxjnl-2015-208107. Epub 2016 Feb 26. Review.

5.

Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.

Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA; Association for the Treatment of Tobacco Use and Dependence/Society for Research on Nicotine and Tobacco Synergy Committee.

Cancer. 2016 Apr 15;122(8):1150-9. doi: 10.1002/cncr.29926. Epub 2016 Feb 24. Review.

PMID:
26916412
6.

Multicentric randomized clinical trial to evaluate the long-term effectiveness of a motivational intervention against smoking, based on the information obtained from spirometry in primary care: the RESET study protocol.

Martin-Lujan F, Santigosa-Ayala A, Piñol-Moreso JL, Sorli-Aguilar M, Flores-Mateo G, Bladé-Creixenti J, Basora-Gallisà J, Sola-Alberich R; RESET Study Group investigators.

BMC Fam Pract. 2016 Feb 4;17:15. doi: 10.1186/s12875-016-0415-1.

7.

Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.

Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER.

Oncologist. 2016 Jan;21(1):40-9. doi: 10.1634/theoncologist.2015-0325. Epub 2015 Dec 28.

PMID:
26712960
8.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

PMID:
26426785
9.

Lung cancer incidence and survival among HIV-infected and uninfected women and men.

Hessol NA, Martínez-Maza O, Levine AM, Morris A, Margolick JB, Cohen MH, Jacobson LP, Seaberg EC.

AIDS. 2015 Jun 19;29(10):1183-93. doi: 10.1097/QAD.0000000000000690.

10.

The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.

Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF.

Nicotine Tob Res. 2016 Jan;18(1):17-24. doi: 10.1093/ntr/ntv037. Epub 2015 Mar 6.

PMID:
25746779
11.

Opportunities to address lung cancer disparities among African Americans.

Coughlin SS, Matthews-Juarez P, Juarez PD, Melton CE, King M.

Cancer Med. 2014 Dec;3(6):1467-76. doi: 10.1002/cam4.348. Epub 2014 Sep 14. Review.

12.

Lung Cancer Screening With Low-Dose CT: Its Effect on Smoking Behavior.

Gomez MM, LoBiondo-Wood G.

J Adv Pract Oncol. 2013 Nov;4(6):405-14. Review.

13.

Impact of lung cancer screening results on smoking cessation.

Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL.

J Natl Cancer Inst. 2014 May 28;106(6):dju084. doi: 10.1093/jnci/dju084. Print 2014 Jun.

14.

Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study.

Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen MH.

Am J Prev Med. 2014 Jul;47(1):53-69. doi: 10.1016/j.amepre.2014.02.010. Epub 2014 Apr 18.

15.

Importance of Smoking Cessation in a Lung Cancer Screening Program.

Munshi V, McMahon P.

Curr Surg Rep. 2013 Dec;1(4). doi: 10.1007/s40137-013-0030-1.

16.

Smoking cessation in lung cancer-achievable and effective.

Andreas S, Rittmeyer A, Hinterthaner M, Huber RM.

Dtsch Arztebl Int. 2013 Oct;110(43):719-24. doi: 10.3238/arztebl.2013.0719. Epub 2013 Oct 25. Review.

17.

A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants.

Park ER, Streck JM, Gareen IF, Ostroff JS, Hyland KA, Rigotti NA, Pajolek H, Nichter M.

Nicotine Tob Res. 2014 Feb;16(2):166-73. doi: 10.1093/ntr/ntt133. Epub 2013 Sep 2.

18.

A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.

Villanti AC, Jiang Y, Abrams DB, Pyenson BS.

PLoS One. 2013 Aug 7;8(8):e71379. doi: 10.1371/journal.pone.0071379. Print 2013.

19.

Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up.

Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA.

Cancer. 2013 Apr 1;119(7):1306-13. doi: 10.1002/cncr.27925. Epub 2012 Dec 20.

20.

Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Barry SA, Tammemagi MC, Penek S, Kassan EC, Dorfman CS, Riley TL, Commin J, Taylor KL.

J Natl Cancer Inst. 2012 Nov 7;104(21):1647-59. doi: 10.1093/jnci/djs398. Epub 2012 Oct 26.

Items per page

Supplemental Content

Write to the Help Desk